432 related articles for article (PubMed ID: 31081595)
1. Effects of Allopurinol Dose Escalation on Bone Erosion and Urate Volume in Gout: A Dual-Energy Computed Tomography Imaging Study Within a Randomized, Controlled Trial.
Dalbeth N; Billington K; Doyle A; Frampton C; Tan P; Aati O; Allan J; Drake J; Horne A; Stamp LK
Arthritis Rheumatol; 2019 Oct; 71(10):1739-1746. PubMed ID: 31081595
[TBL] [Abstract][Full Text] [Related]
2. Radiologic evidence of symmetric and polyarticular monosodium urate crystal deposition in gout - A cluster pattern analysis of dual-energy CT.
Yokose C; Dalbeth N; Wei J; Nicolaou S; Simeone FJ; Baumgartner S; Fung M; Zhang Y; Choi HK
Semin Arthritis Rheum; 2020 Feb; 50(1):54-58. PubMed ID: 31371194
[TBL] [Abstract][Full Text] [Related]
3. Exploratory study of radiographic change in patients with tophaceous gout treated with intensive urate-lowering therapy.
Dalbeth N; Doyle AJ; McQueen FM; Sundy J; Baraf HS
Arthritis Care Res (Hoboken); 2014 Jan; 66(1):82-5. PubMed ID: 23836458
[TBL] [Abstract][Full Text] [Related]
4. A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with gout.
Stamp LK; Chapman PT; Barclay ML; Horne A; Frampton C; Tan P; Drake J; Dalbeth N
Ann Rheum Dis; 2017 Sep; 76(9):1522-1528. PubMed ID: 28314755
[TBL] [Abstract][Full Text] [Related]
5. Relationship between structural joint damage and urate deposition in gout: a plain radiography and dual-energy CT study.
Dalbeth N; Aati O; Kalluru R; Gamble GD; Horne A; Doyle AJ; McQueen FM
Ann Rheum Dis; 2015 Jun; 74(6):1030-6. PubMed ID: 24521739
[TBL] [Abstract][Full Text] [Related]
6. Effects of Conventional Uric Acid-Lowering Therapy on Monosodium Urate Crystal Deposits.
Ellmann H; Bayat S; Araujo E; Manger B; Kleyer A; Cavallaro A; Lell M; Schenker H; Simon D; Tascilar K; Baraf HSB; Schett G; Rech J
Arthritis Rheumatol; 2020 Jan; 72(1):150-156. PubMed ID: 31353871
[TBL] [Abstract][Full Text] [Related]
7. Relationship of bone erosion with the urate and soft tissue components of the tophus in gout: a dual energy computed tomography study.
Sapsford M; Gamble GD; Aati O; Knight J; Horne A; Doyle AJ; Dalbeth N
Rheumatology (Oxford); 2017 Jan; 56(1):129-133. PubMed ID: 27803304
[TBL] [Abstract][Full Text] [Related]
8. Changes in Tophus Composition During Urate-Lowering Therapy: A Dual-Energy Computed Tomography Study.
Chen L; Gamble GD; Horne A; Drake J; Doyle AJ; Uhlig T; Stamp LK; Dalbeth N
Arthritis Care Res (Hoboken); 2023 Sep; 75(9):1949-1954. PubMed ID: 36594401
[TBL] [Abstract][Full Text] [Related]
9. The effect of kidney function on the urate lowering effect and safety of increasing allopurinol above doses based on creatinine clearance: a post hoc analysis of a randomized controlled trial.
Stamp LK; Chapman PT; Barclay M; Horne A; Frampton C; Tan P; Drake J; Dalbeth N
Arthritis Res Ther; 2017 Dec; 19(1):283. PubMed ID: 29268756
[TBL] [Abstract][Full Text] [Related]
10. Lack of change in urate deposition by dual-energy computed tomography among clinically stable patients with long-standing tophaceous gout: a prospective longitudinal study.
Rajan A; Aati O; Kalluru R; Gamble GD; Horne A; Doyle AJ; McQueen FM; Dalbeth N
Arthritis Res Ther; 2013 Oct; 15(5):R160. PubMed ID: 24286500
[TBL] [Abstract][Full Text] [Related]
11. Concurrent validity of provisional remission criteria for gout: a dual-energy CT study.
Dalbeth N; Frampton C; Fung M; Baumgartner S; Nicolaou S; Choi HK
Arthritis Res Ther; 2019 Jun; 21(1):150. PubMed ID: 31227018
[TBL] [Abstract][Full Text] [Related]
12. Intensive Serum Urate Lowering With Oral Urate-Lowering Therapy for Erosive Gout: A Randomized Double-Blind Controlled Trial.
Dalbeth N; Doyle AJ; Billington K; Gamble GD; Tan P; Latto K; Parshu Ram T; Narang R; Murdoch R; Bursill D; Mihov B; Stamp LK; Horne A
Arthritis Rheumatol; 2022 Jun; 74(6):1059-1069. PubMed ID: 34927391
[TBL] [Abstract][Full Text] [Related]
13. Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment.
Stamp LK; O'Donnell JL; Zhang M; James J; Frampton C; Barclay ML; Chapman PT
Arthritis Rheum; 2011 Feb; 63(2):412-21. PubMed ID: 21279998
[TBL] [Abstract][Full Text] [Related]
14. Presence of monosodium urate crystal deposition by dual-energy CT in patients with gout treated with allopurinol.
Dalbeth N; Nicolaou S; Baumgartner S; Hu J; Fung M; Choi HK
Ann Rheum Dis; 2018 Mar; 77(3):364-370. PubMed ID: 29146741
[TBL] [Abstract][Full Text] [Related]
15. Clinically insignificant effect of supplemental vitamin C on serum urate in patients with gout: a pilot randomized controlled trial.
Stamp LK; O'Donnell JL; Frampton C; Drake JM; Zhang M; Chapman PT
Arthritis Rheum; 2013 Jun; 65(6):1636-42. PubMed ID: 23681955
[TBL] [Abstract][Full Text] [Related]
16. New urate depositions on dual-energy computed tomography in gouty arthritis during urate-lowering therapy.
Zhang Z; Zhang X; Sun Y; Chen H; Kong X; Zhou J; Zhou Y; Ma L; Jiang L
Rheumatol Int; 2017 Aug; 37(8):1365-1372. PubMed ID: 28447206
[TBL] [Abstract][Full Text] [Related]
17. Allopurinol dose escalation to achieve serum urate below 6 mg/dL: an open-label extension study.
Stamp LK; Chapman PT; Barclay M; Horne A; Frampton C; Tan P; Drake J; Dalbeth N
Ann Rheum Dis; 2017 Dec; 76(12):2065-2070. PubMed ID: 28830881
[TBL] [Abstract][Full Text] [Related]
18. Urate crystal deposition and bone erosion in gout: 'inside-out' or 'outside-in'? A dual-energy computed tomography study.
Towiwat P; Doyle AJ; Gamble GD; Tan P; Aati O; Horne A; Stamp LK; Dalbeth N
Arthritis Res Ther; 2016 Sep; 18(1):208. PubMed ID: 27629724
[TBL] [Abstract][Full Text] [Related]
19. Can we predict inadequate response to allopurinol dose escalation? Analysis of a randomised controlled trial.
Stamp LK; Chapman PT; Barclay M; Horne A; Frampton C; Tan P; Drake J; Dalbeth N
Rheumatology (Oxford); 2018 Dec; 57(12):2183-2189. PubMed ID: 30107437
[TBL] [Abstract][Full Text] [Related]
20. Systemic staging for urate crystal deposits with dual-energy CT and ultrasound in patients with suspected gout.
Huppertz A; Hermann KG; Diekhoff T; Wagner M; Hamm B; Schmidt WA
Rheumatol Int; 2014 Jun; 34(6):763-71. PubMed ID: 24619560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
